Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Lehn

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Gastroenterology|October 3, 2002
Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trialStephan Miehlke, Peter Heymer, Birgit Bethke, et al.
Helicobacter|January 22, 2008
One-week once-daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for eradication of persistent Helicobacter pylori resistant to both metronidazole and clarithromycinStephan Miehlke, Wulf Schneider-Brachert, Christian Kirsch, et al.
Helicobacter|November 9, 2011
Randomized trial on 14 versus 7 days of esomeprazole, moxifloxacin, and amoxicillin for second-line or rescue treatment of Helicobacter pylori infectionStephan Miehlke, Susanne Krasz, Wulf Schneider-Brachert, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Gastroenterology|October 3, 2002
Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trialStephan Miehlke, Peter Heymer, Birgit Bethke, et al.
Helicobacter|January 22, 2008
One-week once-daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for eradication of persistent Helicobacter pylori resistant to both metronidazole and clarithromycinStephan Miehlke, Wulf Schneider-Brachert, Christian Kirsch, et al.
Helicobacter|November 9, 2011
Randomized trial on 14 versus 7 days of esomeprazole, moxifloxacin, and amoxicillin for second-line or rescue treatment of Helicobacter pylori infectionStephan Miehlke, Susanne Krasz, Wulf Schneider-Brachert, et al.
Pageof 5